| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |